e-learning
resources
Milan 2017
Sunday, 10.09.2017
ILDs: clinical aspects
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Short term Quantitative Lung Fibrosis (QLF) change predicts rapid rate of FVC decline in patients with IPF
J. Goldin (Santa Monica, United States of America)
Source:
International Congress 2017 – ILDs: clinical aspects
Session:
ILDs: clinical aspects
Session type:
Thematic Poster
Number:
853
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Goldin (Santa Monica, United States of America). Short term Quantitative Lung Fibrosis (QLF) change predicts rapid rate of FVC decline in patients with IPF. 853
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
QLF change is more sensitive than FVC change in predicting Progression Free survival (PFS) in IPF trials
Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems
Year: 2017
Global Lung Function Initiative equations improve interpretation of FEV1 decline among patients with cystic fibrosis
Source: Eur Respir J 2015; 46: 262-264
Year: 2015
Variability and bronchodilator response of tracheal forced expiratory noise time parameters in asthma patients and healthy subjects
Source: International Congress 2014 – Airways: reversibility and responsiveness
Year: 2014
Annual rate of FVC decline in patients with IPF treated with pirfenidone: Pooled analysis from 3 pivotal studies
Source: International Congress 2016 – IPF treatment I
Year: 2016
Differences in functional impairment diagnosis using global lung initiative (GLI) predictive values for spirometry
Source: International Congress 2014 – The impact of the Global Lung Initiative (GLI) reference equations and spirometry quality in all ages
Year: 2014
Validation of nitrogen washout (N2-WO) for measurement of lung clearance index (LCI) and functional residual capacity (FRC) in preschoolers
Source: International Congress 2016 – What's new in paediatric respiratory physiology?
Year: 2016
Manual revision of automated lung function grading results in an increase of accepted data and a relevant change in FEV
1
and FVC
Source: International Congress 2014 – The impact of the Global Lung Initiative (GLI) reference equations and spirometry quality in all ages
Year: 2014
Combined Pulmonary Fibrosis and Enphysema (CPFE): correlation between TC parameters and functional decline.
Source: International Congress 2017 – Various imaging modalities for different lung diseases
Year: 2017
Lung Clearance Index (LCI) and diffusion capacity of the lung (DLCO) in children with rheumatic disease
Source: Virtual Congress 2020 – Unusual tools for evaluating obstructive diseases
Year: 2020
Real World experiences: Pirfenidone is well tolerated and reduces decline in FVC and TLCO at 9 months in IPF
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Correlation of nutritional status using subjective global assessment (SGA) on pulmonary function parameters in patients with COPD at the Philippine Heart Center
Source: Annual Congress 2013 –Disease control and quality of life in airway diseases
Year: 2013
Natural decline in FEV
1
and FVC: Self versus reference equations
Source: Annual Congress 2013 –Reference, reliability and risk: advances in lung function
Year: 2013
Percent predicted forced vital capacity (FVC) is a reliable, valid, and responsive measure of clinical status in patients with idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2010 - Clinical issues in idiopathic pulmonary fibrosis
Year: 2010
The ratio of inspiratory ΣRrs to expiratory ΣRrs measured by forced oscillation technique correlates with the parameters reflecting narrowing of small airway measured by spirometry in patients with mild to moderate COPD
Source: Annual Congress 2013 –New issues in lung function testing
Year: 2013
Measuring lung function in asthmatic children: A spirometry and forced oscillation technique (FOT) comparison
Source: International Congress 2016 – Highlights in primary ciliary dyskinesia and asthma in childhood
Year: 2016
Association between weight loss and decline in FVC in patients with IPF
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019
Lung clearance index is increased in patients with COPD
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Lung function indices measured by Forced Oscillation Test in post covid period - Looking beyond lung fibrosis
Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects
Year: 2021
Lung Clearance Index (LCI) derived from N2-Multiple Breath Washout (MBW) depicts worsening in airways colonization in pediatric Cystic Fibrosis (CF) patients (pts)
Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis
Year: 2020
Forced oscillation technique (FOT) in relation to exercise-induced dyspnea without FEV
1
-fall – Results from ANDAS-study
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept